Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF.
This prospective randomized study compared human chorionic gonadotropin (hCG) and micronized transvaginal progesterone for luteal support in 310 in vitro fertilization (IVF) patients treated with leuprolide acetate and gonadotropins in a long protocol, and showing normal ovarian response. Both treatment groups were homogeneous for age, BMI, stimulation treatment and ovarian response. Pregnancy rates per embryo transfer were not significantly different (33.1% for the hCG group versus 38.7% for the progesterone group). For IVF patients with a normal response to stimulation under pituitary suppression, the use of hCG or progesterone for luteal support does not seem to have any effect on pregnancy rate. The choice of luteal treatment must balance medical hazard and patient convenience, as both therapeutic regimens seem equally effective.
Martinez
F
F
Department of Obstetrics and Gynaecology, Institut Universitari Dexeus, Barcelona, Spain.
Coroleu
B
B
Parera
N
N
Alvarez
M
M
Traver
J M
JM
Boada
M
M
Barri
P N
PN
D000282:Administration, Intravaginal; D000328:Adult; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D008183:Luteal Phase / Q000502:physiology*; D009865:Oocytes; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome
D006063:Chorionic Gonadotropin; D011374:Progesterone; D004958:Estradiol